CARYX | DRRCX | CARYX / DRRCX | |
Total Expense Ratio | 0.77 | 1.93 | 40% |
Annual Report Gross Expense Ratio | 0.77 | 2.00 | 39% |
Fund Existence | 11 years | 15 years | - |
Gain YTD | 3.657 | 1.701 | 215% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.39B | 879M | 271% |
Annual Yield % from dividends | 2.49 | 4.20 | 59% |
Returns for 1 year | 7.09 | 3.33 | 213% |
Returns for 3 years | 13.95 | 5.08 | 275% |
Returns for 5 years | 8.45 | 15.87 | 53% |
Returns for 10 years | 25.37 | 27.52 | 92% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GCSSX | 23.99 | N/A | N/A |
Goldman Sachs Small Cap Eq Insghts Svc | |||
COCVX | 12.71 | N/A | N/A |
Columbia Overseas Value C | |||
RTITX | 11.72 | N/A | N/A |
Russell Inv Multifactor Intl Eq M | |||
VDIPX | 28.20 | N/A | N/A |
Vanguard Developed Markets Index Ins Pls | |||
JCAVX | 9.31 | N/A | N/A |
JHFunds2 Capital Appreciation Value NAV |